The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase
Abstract
Objective: Gluten sensitivity typically presents as celiac disease, a chronic, autoimmune‐mediated, small‐intestinal disorder. Neurological disorders occur with a frequency of up to 10% in these patients. However, neurological dysfunction can also be the sole presenting feature of gluten sensitivity. Development of autoimmunity directed toward different members of the transglutaminase gene family could offer an explanation for the diversity in manifestations of gluten sensitivity. We have identified a novel neuronal transglutaminase isozyme and investigated whether this enzyme is the target of the immune response in patients with neurological dysfunction. Methods: Using recombinant human transglutaminases, we developed enzyme‐linked immunosorbent assays and inhibition assays to analyze serum samples of patients with gluten‐sensitive gastrointestinal and neurological disorders, and various control groups including unrelated inherited or immune conditions for the presence and specificity of autoantibodies. Results: Whereas the development of anti‐transglutaminase 2 IgA is linked with gastrointestinal disease, an anti‐transglutaminase 6 IgG and IgA response is prevalent in gluten ataxia, independent of intestinal involvement. Such antibodies are absent in ataxia of defined genetic origin or in healthy individuals. Inhibition studies showed that in those patients with ataxia and enteropathy, separate antibody populations react with the two different transglutaminase isozymes. Furthermore, postmortem analysis of brain tissue showed cerebellar IgA deposits that contained transglutaminase 6. Interpretation: Antibodies against transglutaminase 6 can serve as a marker in addition to human leukocyte antigen type and detection of anti‐gliadin and anti‐transglutaminase 2 antibodies to identify a subgroup of patients with gluten sensitivity who may be at risk for development of neurological disease. Ann Neurol 2008;64:332–343
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of tissue transglutaminase as the autoantigen of celiac disease
Dieterich, W., Ehnis, T., Bauer, M., Donner, P., Volta, U., Riecken, E. O., & Schuppan, D. (1997) · Nature Medicine · doi:10.1038/nm0797-797 · Cited by 2,028
Molberg, Ø., Mcadam, S. N., Körner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L., Scott, H., Norén, O., Roepstorff, P., et al. (1998) · Nature Medicine · doi:10.1038/nm0698-713 · Cited by 1,168
Coeliac disease: dissecting a complex inflammatory disorder
Sollid, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri885 · Cited by 964
Karell, K., Louka, A. S., Moodie, S. J., Ascher, H., Clot, F., Greco, L., Ciclitira, P. J., Sollid, L. M., & Partanen, J. (2003) · Human Immunology · doi:10.1016/s0198-8859(03)00027-2 · Cited by 613
Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis
Sárdy, M., Kárpáti, S., Merkl, B., Paulsson, M., & Smyth, N. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011299 · Cited by 517
van de Wal, Y., Kooy, Y. M. C., van Veelen, P. A., Peña, S., Mearin, L., Papadopoulos, G. K., & Koning, F. (1998) · PubMed · Cited by 490
Transglutaminase 2 Undergoes a Large Conformational Change upon Activation
Pinkas, D. M., Strop, P., Brunger, A. T., & Khosla, C. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050327 · Cited by 450
van de Wal, Y., Kooy, Y., van Veelen, P., Peña, S., Mearin, L., Papadopoulos, G., & Koning, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1585 · Cited by 432
Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia
Hadjivassiliou, M., Grünewald, R., Chattopadhyay, A., Davies-Jones, G., Gibson, A., Jarratt, J., Kandler, R., Lobo, A., Powell, T., & Smith, C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05342-2 · Cited by 415
Self-citationHuman lupus autoantibodies against NMDA receptors mediate cognitive impairment
Kowal, C., DeGiorgio, L. A., Lee, J. Y., Edgar, M. A., Huerta, P. T., Volpe, B. T., & Diamond, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608397104 · Cited by 415
Cited by
The Oslo definitions for coeliac disease and related terms
Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301346 · Cited by 1,721
Self-citationSpectrum of gluten-related disorders: consensus on new nomenclature and classification
Sapone, A., Bai, J. C., Ciacci, C., Dolinsek, J., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Rostami, K., Sanders, D. S., Schumann, M., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-13 · Cited by 1,140
Self-citationGluten sensitivity: from gut to brain
Hadjivassiliou, M., Sanders, D. S., Grünewald, R. A., Woodroofe, N., Boscolo, S., & Aeschlimann, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70290-x · Cited by 404
Self-citationCeliac Disease and Nonceliac Gluten Sensitivity: A Review
Leonard, M. M., Sapone, A., Catassi, C., & Fasano, A. (2017) · JAMA · doi:10.1001/jama.2017.9730 · Cited by 391
Iismaa, S. E., Mearns, B. M., Lorand, L., & Graham, R. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00044.2008 · Cited by 328
Metadata
- Authors
- Hadjivassiliou, M., Aeschlimann, P., Strigun, A., Sanders, D. S., Woodroofe, N., & Aeschlimann, D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-09-28
- Volume
- 64
- Issue
- 3
- Pages
- 332-343
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2153833918
- Cited by
- 273
- References
- 46
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. https://app.cochat.ai/papers/10.1002/ana.21450
- The paper
- Hadjivassiliou, M., Aeschlimann, P., Strigun, A., Sanders, D. S., Woodroofe, N., & Aeschlimann, D. (2008). Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Annals of Neurology. https://doi.org/10.1002/ana.21450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.